ADX10059 a Negative Allosteric Modulator of the Metabotropic Glutamate 5 Receptor (mGlur5) Effectively Controls Chorea and Dystonia in a Primate Model of Levodopa Induced Dyskinesia

被引:0
|
作者
Keywood, Charlotte G.
Bezard, Erwan
Girard, Francoise
Mutel, Vincent
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A393 / A393
页数:1
相关论文
共 50 条
  • [41] Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5
    Fuxe, Kjell
    Borroto-Escuela, Dasiel O.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (09) : 1247 - 1260
  • [42] A single-blind, placebo-controlled, proof of concept study of the effect of the mGlur5 negative allosteric modulator, ADX10059, on 24hour esophageal PH and clinical symptoms, in patient's with gastro-esophageal reflux disease (GERD)
    Keywood, C.
    Wakefield, Mark
    NEUROPHARMACOLOGY, 2008, 55 (04) : 604 - 605
  • [43] Metabotropic glutamate receptor type 5 (mGluR5) antagonists improve L-DOPA-induced-dyskinesia in both rat and macaque models of Parkinson's disease
    Rylander, D.
    Li, Q.
    Dekundy, A.
    Li, H.
    Baishen, R.
    Danysz, W.
    Bezard, E.
    Cenci, A.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S132 - S132
  • [44] A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
    Tison, Francois
    Keywood, Charlotte
    Wakefield, Mark
    Durif, Franck
    Corvol, Jean-Christophe
    Eggert, Karla
    Lew, Mark
    Isaacson, Stuart
    Bezard, Erwan
    Poli, Sonia-Maria
    Goetz, Christopher G.
    Trenkwalder, Claudia
    Rascol, Olivier
    MOVEMENT DISORDERS, 2016, 31 (09) : 1373 - 1380
  • [45] Up-regulation of metabotropic glutamate receptor 5 (mGluR5) mRNA in spinal cord in a clinical model of inflammation and hyperalgesia
    Dolan, S
    Kelly, JG
    Nolan, AM
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137
  • [46] Safety, Tolerability and Anti-Dyskinetic Efficacy of Dipraglurant, a Novel mGluR5 Negative Allosteric Modulator (NAM) in Parkinson's Disease (PD) Patients with Levodopa-Induced Dyskinesia (LID)
    Tison, Francois
    Durif, Franck
    Corvol, Jean Christophe
    Eggert, Karla
    Trenkwalder, Claudia
    Lew, Mark
    Isaacson, Stuart
    Keywood, Charlotte
    Rascol, Olivier
    NEUROLOGY, 2013, 80
  • [47] Potential anxiolytic- and antidepressant-like activity of Dipraglurant (ADX48621), the novel negative allosteric modulator (NAM) of the metabotropic glutamate 5 (mGlu5) receptor
    Podkowa, Karolina
    Palucha-Poniewiera, Agnieszka
    Poli, Sonia
    Pilc, Andrzej
    PHARMACOLOGICAL REPORTS, 2015, 67 : 34 - 35
  • [48] Anti-parkinsonian and Anti-Dyskinetic Effects of Dipraglurant (ADX48621), a Novel mGluR5 Negative Allosteric Modulator in Clinical Development
    Poli, Sonia
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 53 - 54
  • [49] VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
    Nickols, Hilary Highfield
    Yuh, Joannes P.
    Gregory, Karen J.
    Morrison, Ryan D.
    Bates, Brittney S.
    Stauffer, Shaun R.
    Emmitte, Kyle A.
    Bubser, Michael
    Peng, Weimin
    Nedelcovych, Michael T.
    Thompson, Analisa
    Lv, Xiaohui
    Xiang, Zixiu
    Daniels, J. Scott
    Niswender, Colleen M.
    Lindsley, Craig W.
    Jones, Carrie K.
    Conn, P. Jeffrey
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (01): : 123 - 136
  • [50] VU0477573: Partial negative allosteric modulator of the subtype 5 metabotropic glutamate receptor with in vivo efficacy
    Nickols, Hilary
    Nickols, Hilary
    Gregory, Karen
    Morrison, Ryan
    Bates, Brittney
    Stauffer, Shaun
    Emmitte, Kyle
    Bubser, Michael
    Peng, Weimin
    Nedelcovych, Michael
    Thompson, Analisa
    Daniels, J.
    Niswender, Colleen
    Jones, Carrie
    Lindsley, Craig
    Conn, P.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 618 - 618